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ABSTRACT
Exposure therapy is theorized to reduce posttraumatic stress disorder (PTSD)
symptomatology by promoting habituation/extinction of fear responses to trauma-related cues.
Empirical evidence indicates that emotional memory, including habituation/extinction learning,
is enhanced by sleep. However, service members with combat-related PTSD often report
disturbed sleep. In this study, quality of sleep and indicators of extinction learning were
examined in veterans of recent wars who had completed an exposure-based PTSD intervention.
Fifty-five participants were categorized into two groups based on self-reported quality of sleep:
low sleep disruption severity (LSDS; N = 29) and high sleep disruption severity (HSDS; N = 26).
Participants in the LSDS group exhibited faster habituation to their traumatic memories and
reported less PTSD symptomatology during and following treatment relative to participants in
the HSDS group. These findings indicate that individuals with combat-related PTSD reporting
less disturbed sleep experience greater extinction learning during exposure therapy. Thus,
incorporating interventions that target PTSD-related sleep disturbances may be one way to
maximize exposure therapy outcomes in service members with PTSD.
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CHAPTER 1: INTRODUCTION
In March of 2014, the United States Department of Veterans Affairs (VA) reported that
more than 1.05 million veterans of Operation Enduring Freedom (OEF), Operation Iraqi
Freedom (OIF) and Operation New Dawn (OND) have sought medical or psychiatric services at
a VA facility (VA, 2014). More than 56% of these service members received at least one
psychiatric diagnosis, a proportion surpassed only by diagnoses of musculoskeletal and
connective tissue diseases. The most frequently diagnosed psychiatric disorder is posttraumatic
stress disorder (PTSD). PTSD is conceptualized as a constellation of psychological symptoms
developing after a traumatic experience in which an individual is exposed to actual or threatened
death, serious injury or sexual violence (APA, 2013). The prolonged use of ground combat and
occupation in the recent US military engagements has exposed a large proportion of service
members to a variety of extremely stressful and threatening situations, including receiving
gunfire, handling other service members killed in action, witnessing the detonation of improvised
explosive devices or killing enemy combatants (Hoge et al., 2004; Kline et al., 2010). Thus,
military personnel deployed to combat zones are clearly at an increased risk to develop PTSD.
The symptoms of the disorder begin after a traumatic experience and are categorized into
four clusters: intrusion (e.g., trauma-related nightmares and flashbacks); avoidance (e.g.,
avoidance of trauma-related thoughts or feelings or external reminders); negative alterations in
cognitions and mood (e.g., significantly decreased interest in activities and feelings of
detachment from others); and alterations in arousal (e.g., hypervigilance and sleep disturbance;
APA, 2013). Although presently conceptualized as a symptom of PTSD, sleep disturbances have
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received increased attention as a potential core feature of the disorder (Babson & Feldner, 2010;
Spoormaker & Montgomery, 2008).
Many individuals report acute sleep disturbances after a traumatic event (Babson &
Feldner, 2010), a response that perhaps is a normal reaction to significant stress (Bonanno, 2004;
Pillar, Malhotra & Lavie, 2000). Among survivors of a natural disaster, sleep disturbance was the
most frequently endorsed symptom, as 63% and 46% reported difficulty sleeping at 3- and 8
weeks posttrauma, respectively (Kato, Asukai, Miyake, Minakawa & Nisiyama, 1996).
Similarly, 70% of survivors of the 1995 bombing of US federal offices reported sleep
disturbances, with more than half endorsing trauma-related nightmares six months after the
trauma (North et al., 1999). Additionally, empirical evidence suggests that sleep disturbances
begin soon after a trauma and may be precursors of the later onset of PTSD. In these studies,
self-reported insomnia at one month posttrauma predicted a diagnosis of PTSD 12 months later
(Koren, Amon, Lavie & Klein, 2002) and trauma-related nightmares soon after a trauma were
related to significantly increased PTSD severity 6 weeks later (Mellman, David, Bustamante,
Torres & Fins, 2001). Furthermore, Luxton and colleagues (2011) found that service members
with combat experiences (not necessarily defined as traumatic events) were more likely than
service members without such experiences to report shortened sleep durations (i.e., less than 6
hours). In turn, reduced sleep duration was related to an increased the risk of screening positive
for PTSD.
Rates of sleep disturbances are predictably elevated among individuals diagnosed with
PTSD, as the common occurrence of insomnia and nightmares may interrupt sleep and create
anticipatory anxiety about sleep periods (Harvey et al., 2003). Accordingly, combat veterans
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with PTSD frequently report multiple sleep difficulties, including initial, middle and late
insomnia, nightmares (with combat and non-combat themes), startle awakenings and violent
movement/thrashing in bed (Mellman, Kulick-Bell, Ashlock & Nolan, 1995; Neylan et al.,
1998). However, although subjective reports of sleep disturbance are consistent in patients with
PTSD, objective examinations of sleep have produced mixed outcomes and do not always
coincide with the subjective reports (Harvey et al., 2003). Using polysomnography, prior studies
have found significantly reduced sleep efficiency (Mellman et al., 1995; Mellman, Nolan,
Hebding, Kulick-Bell & Dominguez, 1997) and more frequent awakenings (Mellman et al.,
1995; Mellman, David, Kulick-Bell, Hebding & Nolan, 1995) in individuals with PTSD,
indicating that more time was spent awake during sleep periods relative to controls. Other studies
have failed to find these effects using actigraphy (Dagan, Zinger, & Lavie, 1997) or
polysomnography (Engdahl, Eberly, Hurwitz, Mahowald, & Blake, 2000; Hurwitz, Mahowald,
Kuskowski, & Engdahl, 1998), instead reporting that civilians and combat veterans with PTSD
may overestimate their sleep latency and underestimate their total sleep duration. Nevertheless, a
meta-analysis of polysomnographic examinations of sleep in patients with PTSD revealed
greater rapid eye movement (REM) density (i.e., greater frequency of eye movements per unit of
time), reduced slow wave sleep (stages 3 and 4 of non-REM (NREM)), and greater stage 1 sleep
relative to individuals without PTSD (Kobayashi, Boarts & Delahanty, 2007). REM sleep is
characterized by paradoxical general paralysis of the body accompanied by rapid eye movements
and the peak of brain activity during sleep. Most dreams occur during REM stages, which
become progressively longer and consume a larger proportion of the sleep cycle later in the sleep
period. In contrast, NREM sleep consists of four stages (stages 1 through 4) wherein sleep
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progressively deepens from stage 1 to stage 4 (Shneerson, 2000). Thus, the meta-analytic
findings support the occurrence of the nightmares during REM stages and increased light, nonrestorative sleep among individuals with PTSD.
Sleep disturbances experienced with PTSD contribute significantly to daytime
impairment and may contribute to the maintenance of the disorder (Belleville, Guay &
Marchand, 2009; Maher, Rego & Asnis, 2006; Rothbaum & Mellman, 2001; Spoormaker &
Montgomery, 2008). In addition to impaired work and social functioning, deficits in cognitive
functioning may occur as well. For example, a considerable volume of empirical evidence
indicates that sleep has a significant effect on memory consolidation (for review see Diekelman,
Wilhelm & Born, 2009). As defined by Diekelmann and Born (2010), consolidation is the
process whereby new memories encoded during wake periods become stable representations and
are integrated into the network of preexisting long-term memories. The consolidation of memory
and learning are enhanced by subsequent sleep, including emotional memories and learning. This
effect seems to be mediated largely by the amygdala and its projections to other areas of the
brain involved in memory consolidation, such as the hippocampus (McGaugh, 2004; Phelps &
LeDoux, 2005). Amygdala activity is heightened during REM sleep (Maquet et al., 1996;
Nofzinger, 2005), which is the specific stage of sleep often found to enhance emotional memory
consolidation (Diekelman et al., 2009). Furthermore, greater emotional memory consolidation is
associated with enhanced activity in hippocampal and medial prefrontal cortical (mPFC) regions
(Sterpenich et al., 2007), indicating that amygdala activity during REM may enhance
connectivity between the hippocampus and mPFC (Diekelman et al., 2009). These brain regions
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are implicated in functional neuroanatomical examinations of PTSD (Liberzon & Sripada, 2007)
as well as fear conditioning and extinction (Moustafa et al., 2013).
To date, exposure-based interventions have demonstrated the greatest efficacy in
reducing combat-related PTSD symptomology (Foa, Hembree, & Rothbaum, 2007; Frueh,
Turner & Beidel, 1995; Goodson et al., 2011; Institute of Medicine, 2007). Based on an
extinction paradigm, exposure therapy for PTSD is intended to produce habituation, or reduced
physiological, behavioral and/or cognitive conditioned (learned) fear responses, to traumarelated cues. This is accomplished through controlled, systematic and repeated contact with
feared, trauma-related cues in the absence of actual threat for an extended duration of time
(Rothbaum & Schwartz, 2002). This process, called extinction learning, is theorized to weaken
the fear-based associations and stimulate the formation of new inhibitory associations that
compete with the prior associations (McNally, 2007).
Emerging evidence supports the notion that the enhancing effects of sleep on emotional
memory may bolster the learning processes targeted by exposure therapy (Harvey et al., 2014).
In an examination of habituation/extinction, Pace-Schott and colleagues (2011) repeatedly
presented negatively-valenced or neutral images during two sessions. The sessions were
separated by a 2.5 hour period during which participants either slept for 120 minutes or remained
awake. Participants who slept demonstrated greater between-session sympathetic habituation
(i.e., significantly fewer skin conductance responses in session two relative to session one) to
repeated images. However, habituation was not observed in heart rate or subjective ratings of
emotional valence and arousal. In another study, Pace-Schott and colleagues (2009) evaluated
the effect of sleep on habituation/extinction learning retention. The authors implemented a
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classical conditioning paradigm wherein two stimuli were paired with a mild shock.
Subsequently, one conditioned stimulus was extinguished by repeated presentations without a
shock. Following the extinction trials, participants either completed a full night of sleep or
remained awake for 12 hours. The stimuli were then presented again. Significantly fewer skin
conductance responses to the unextinguished stimulus were observed in the sleep group,
demonstrating generalization of extinction of the extinction process. Moreover, although the
sleep group exhibited less sympathetic activation to the extinguished stimulus (d = .31), the
result was not statistically significant.
More recent investigations have examined the effect of sleep on extinction learning in
exposure-based paradigms. While measuring physiological responses, Pace-Schott and
colleagues (2012) repeatedly exposed individuals with spider phobia to a spider stimulus. After a
delay consisting of a full night of sleep or a 12-hour wake period, participants were repeatedly
presented the prior stimulus again followed by repeated presentations of a novel spider stimulus.
When presented with the previous spider the second time, distress ratings and skin conductance
responses increased in the group that remained awake (wake group). Additionally, the wake
group demonstrated sensitization, as evidenced by an increased distress and sympathetic
response when they were later shown the novel spider. In contrast, relative to their initial
responses to the first spider, the sleep group exhibited reduced physiological reactivity to the
novel spider. Thus, while the wake group failed to retain extinction learning and developed
sensitization of the fear response, the sleep group demonstrated greater generalization of
extinction learning. These findings support the beneficial effects of sleep on exposure therapy.
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Approaching a more traditional exposure therapy procedure, Kleim and colleagues
(2013) examined the effect of sleep on extinction learning among individuals diagnosed with
spider phobia. Participants completed a single, 45-minute session of virtual reality (VR)
exposure followed by a 90-minute sleep or wake period. While the groups did not differ when
assessed immediately after the 90-minute period, the sleep group reported significantly reduced
distress ratings and negative spider-related cognitions relative to the wake group 1 week later.
Collectively, these studies support the enhancing effects of sleep on exposure-based
extinction learning. They also point to one reason why the efficacy of exposure-based therapy for
PTSD may be attenuated in combat veterans. Specifically, if one of the cardinal complaints of
PTSD is sleep disturbance, then one might expect less consolidation of learning (and therefore
poorer outcome) in patients with primary sleep complaints. Presently, the effect of sleep on
habituation and extinction learning in a population where sleep disturbance is a primary
complaint (e.g., combat-related PTSD) is unknown. As a next step in understanding the role of
sleep in the treatment of PTSD, this study examined the relationship between self-reported
quality of sleep and extinction learning during an intensive exposure-based intervention in
military personnel with combat-related PTSD. The following hypotheses were evaluated:
1) Participants with less self-reported sleep disruption will exhibit significantly greater
reductions in peak ratings of distress across exposure sessions.
2) Participants with less self-reported sleep disruption will exhibit significantly greater
reductions in baseline ratings of distress across exposure sessions.
3) Participants with less self-reported sleep disruption will achieve overall habituation in
fewer sessions.
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4) Participants with less self-reported sleep disruption will report fewer symptoms of PTSD
following treatment.
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CHAPTER 2: METHOD
Data were collected from OEF/OIF military personnel who participated in a Department
of Defense-funded clinical trial of a 3-week intensive behavioral intervention for combat-related
PTSD, described below, between the dates of May, 2011 and December, 2014. Recruitment
strategies for the trial included advertising through various forms of media (e.g., web, radio and
local news broadcasts), clinician and case manager referral, and military and community-based
events. All participants included in the present study met DSM-IV-TR (APA, 2000) diagnostic
criteria for PTSD. Veterans who evidenced primary psychosis, substance dependence, medical
conditions that precluded participation in exposure therapy (e.g., cardiac conditions) or
suicidality during the intake assessment were excluded from the trial and referred to appropriate
service providers. Most participants were prescribed psychiatric medications. Participants were
asked to not change current dosages. Medication usage was recorded weekly and any changes
were noted. Only one participant included in the present study reported a change in medication
during the trial.
The data in this study were from 55 OEF/OIF service members with combat-related
PTSD who completed the 3-week program. They were categorized into two groups based on
quality of sleep using a procedure described below. Sample demographics and characteristics by
group may be found in Table 1.

Treatment
Trauma Management Therapy (TMT; Frueh, Turner, Beidel, Mirabella & Jones, 1996;
Turner, Beidel & Frueh, 2005) is a comprehensive behavioral intervention for PTSD consisting
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of individual, VR-assisted exposure therapy and by group-based social skills training, anger
management and brief behavioral activation for depression. The intervention has demonstrated
efficacy in improving combat-related PTSD in Vietnam War veterans (Beidel, Frueh, Uhde,
Wong & Mentrikoski, 2011; Frueh et al., 1996). Data for this study were drawn from participants
who completed a 3-week long adaptation of TMT in which individual VR-assisted exposure
therapy was delivered in the morning and group therapy in the afternoon on each weekday.
During the first individual session of TMT, clinicians gathered additional information
about the combat trauma to compose imaginal exposure scenes. Various visual and auditory VR
stimuli, as well as olfactory cues, were tested for similarity with the patient’s experience and
were included during exposure therapy when appropriate. Furthermore, participants were
oriented to the 9-point subjective units of distress scale (SUDS) and instructed to report ratings
of distress due only to the imaginal scene. Imaginal exposure therapy began in the second
session. Exposure sessions typically continued until within-session habituation was achieved
(i.e., at least 50% reduction in peak SUDS or return to baseline SUDS) or 90 minutes of
exposure had elapsed. Some patients progressed to in vivo exposure therapy after habituating to
their imaginal scene. However, for the purposes of this investigation, data to examine extinction
learning were drawn only from VR-assisted imaginal exposure sessions. All participants also
received group therapy each day.
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Measures
Clinician-Administered PTSD Scale (CAPS)
The CAPS (Blake et al., 1995) is a semi-structured interview to assess for DSM-IV-TR
criteria of PTSD. Symptoms are rated by frequency and severity from 0 (not present) to 4
(extremely frequent/severe), the sum of which produces the total score. Subjective distress and
social and occupational functioning are also evaluated. The CAPS has demonstrated acceptable
psychometric properties and diagnostic utility (Weathers, Keane & Davidson, 2001). The
interviews were completed at pretreatment and 1-week posttreatment by licensed clinical
psychologists, post-doctoral fellows, and doctoral students trained previously by a licensed
clinical psychologist familiar with the CAPS. Twenty percent of CAPS interviews were
randomly selected for review by a second rater for interrater reliability purposes. Analyses
revealed excellent consistency for CAPS total scores (ICC = .995) and PTSD diagnosis (k =
1.00).
PTSD Checklist – Military Version (PCL-M).
The PCL-M (Weathers, Litz, Herman, Huska, & Keane, 1993) is a 17-item self-report
measure of PTSD symptoms related to traumatic military experiences. Although the measure is
typically used to assess past month symptoms on a 5-point Likert scale ranging from 1 (not at
all) to 5 (extremely), participants in this study evaluated the severity of past-week
symptomatology. The measure was administered at the beginning of each week of the protocol
(e.g., pretreatment/week 1, week 2, and week 3) and during the posttreatment assessment 1 week
after the completion of treatment. The PCL-M is widely used with military samples and has
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demonstrated excellent reliability and convergent validity with other measures of PTSD
(Blanchard, Jones-Alexander, Buckley, & Forneris, 1996; Wilkins, Lang, & Norman, 2011).
Pittsburgh Sleep Quality Index Addendum for PTSD (PSQI-A)
The PSQI-A (Germain, Hall, Krakow, Shear & Buysse, 2005) is a self-report measure of
past month disruptive nocturnal behaviors (e.g., nightmares or hot flashes during sleep) related to
PTSD. The measure consists of 7 items rated from 0 (not during the past month) to 3 (three or
more times a week) and produces a total score ranging from 0 to 21. Prior investigations have
demonstrated that a total score ≥ 4 on the PSQI-A reliably indicates a diagnosis of PTSD
(Germain et al., 2005; Insana, Hall, Buysse & Germain, 2013). The PSQI-A was administered
during the pretreatment and posttreatment assessments.
Subjective Units of Distress (SUDS)
SUDS during exposure sessions were rated on a 9-point scale ranging from 0 (no anxiety)
to 8 (extreme anxiety). Clinicians obtained a baseline SUDS prior to initiating exposure therapy.
Afterward, SUDS were obtained every 5 to 10 minutes until the end of the session.

Procedure
Participants were classified into two groups based on quality of sleep during treatment:
low sleep disruption severity (LSDS) and high sleep disruption severity (HSDS). A median split
of the posttreatment PSQI-A determined group assignment, as the posttreatment measure
included the treatment period (i.e., “in the last month”) in its targeted timeframe. Thus, given the
median score of 10, thirty participants were labeled LSDS (PSQI-A ≤ 10) and 26 participants
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were labeled HSDS (PSQI-A > 10). Table 2 contains descriptive statistics of the PSQI-A
completed at posttreatment.
Extinction learning variables were extracted from the SUDS ratings gathered during
imaginal exposure sessions. Expectedly, the number of sessions completed varied across
participants. Therefore, sessions were aggregated into three periods (Early, Mid, and Late
sessions). Each participant’s sessions were grouped such that each period contained as close to
an equal number of sessions as possible. For instance, ten sessions of data were divided into four
Early, three Mid, and three Late sessions. Baseline SUDS level prior to scene initiation and peak
SUDS level after scene initiation were extracted for each session and averaged by period,
resulting in three peak and baseline SUDS means for each participant. Additionally, we
examined habituation rate, defined as the number of imaginal exposures completed until peak
SUDS rating across sessions decreased by 50%.

Data Preparation and Statistical Analysis
Prior to performing statistical analyses, the data set was surveyed for completeness. One
week 3 and one posttreatment PCL-M were not present. These missing values were replaced by
the scores from the participants’ preceding PCL-M assessments. Additionally, one participant
did not complete the post-treatment CAPS and was not included in the CAPS analyses.
Subsequently, the variables of interest were examined for normality and univariate outliers
within each group. All variables were reasonably normally distributed and did not have outliers,
with the exception of Late Baseline SUDS which contained one outlier in the LSDS group. The
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outlier was dropped from the group and all further analyses. Examination of Mahalanobis
distances did not indicate any multivariate outliers.
Group differences in peak and baseline SUDS across exposure sessions were examined
with 2 (group) by 3 (time) mixed factorial ANOVAs. Change in PCL-M total score was assessed
with a 2 (group) by 4 (time) mixed factorial ANOVA. Similarly, change in CAPS total score was
examined with a 2 (group) by 2 (time) mixed factorial ANOVA. In instances where the
assumption of sphericity was violated, the appropriate correction was applied to the significance
test (i.e., Greenhouse-Geiser if ɛ < .75 and Huynh-Feldt if ɛ > .75). Analyses that resulted in
significant main effects or group by time interactions were followed by post-hoc comparisons.
Finally, an independent groups t-test was conducted to evaluate mean overall extinction rate.
Descriptive statistics and between-group significance testing of habituation measures and
symptomatology are contained in Table 3.
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CHAPTER 3: RESULTS

Habituation Measures
Peak SUDS level
Analysis of peak SUDS level revealed a significant main effect of time, F(1.642, 85.77) =
182.197, p < .001, ηp2 = .778, but not group, F(1, 52) = 2.880, p < .096, ηp2 = .052. Additionally,
a significant group by time interaction was observed, F(1.642, 85.77) = 4.611, p = .018, ηp2 =
.081. Post-hoc examination of the simple effects indicated that while there were no group
differences in peak SUDS level during Early (p = .446) or Mid (p = .528) sessions, participants
in the LSDS group reported lower peak SUDS level during Late sessions relative to participants
in the HSDS group (F(1,52) = 6.221, p = .016, ηp2 = .107).
Baseline SUDS Level
With respect to baseline SUDS level, only a significant main effect of time was indicated,
F(1.744, 90.685) = 82.389, p < .001, ηp2 = .613. There was no effect of group, F(1, 52) = .039, p
= .844, ηp2 = .001. Similarly, the group by time interaction was not significant, F(1.744, 90.685)
= 1.632, p = .204, ηp2 = .030.
Habituation Rate
Participants with LSDS achieved overall habituation to their primary imaginal scene in
fewer sessions than participants with HSDS, adjusted t(41.703) = -2.149, p = .037.
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PTSD Symptomatology
PCL-M
The mixed factorial ANOVA for the PCL-M revealed significant main effects for time,
F(2.754, 143.201) = 78.782, p < .001, ηp2 = .602, and group, F(1, 52) = 10.672, p = .002, ηp2 =
.170, as well as a significant group by time interaction, F(2.754, 143.201) = 8.338, p < .001, ηp2
= .138. Further evaluation of the PCL-M means indicated that there were no group differences in
self-reported PTSD symptomatology at pretreatment/week 1 (p = .157) or week 2 (p = .089).
However, service members in the LSDS group endorsed significantly less PTSD symptom
severity than service members in the HSDS group at week 3, F(1, 52) = 4.718, p = .034, ηp2 =
.083, and posttreatment, F(1, 52) = 27.477, p < .001, ηp2 = .346. This result was unchanged when
the analysis was repeated with the sleep item removed from the PCL-M total scores for each
participant.
Additionally, all within-group pairwise comparisons in the LSDS group indicated
significant reductions in symptomatology over time (all ps ≤ .001). However, although the HSDS
group evidenced significantly reduced PCL-M total from pretreatment/week 1 to week 2 and
week 2 to week 3 (p < .001 and p = .005, respectively), the PCL-M increased significantly from
week 3 to posttreatment (p = .025) in this group. At posttreatment, the HSDS group’s mean PCLM was not significantly different (p = .264) from the group mean at week 2.
CAPS
For the CAPS, significant main effects for time, F(1, 50) = 298.077, p < .001, ηp2 = .856,
and group, F(1, 50) = 13.259, p = .001, ηp2 = .210, and a significant interaction, F(1, 50) = 6.383,
p = .015, ηp2 = .113, were found. Post-hoc analyses revealed a significant group difference in
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posttreatment CAPS total, F(1, 50) = 13.925, p < .001, ηp2 = .218, as the LSDS group exhibited
less clinician-rated PTSD symptomatology than the HSDS group. There was no pretreatment
group difference in CAPS total (p = .172).

Additional Findings
Habituation Achieved
To further examine extinction learning, the proportion of participants in each group that achieved
the criterion for habituation (e.g., a 50% reduction in peak SUDS rating across exposure
sessions) was evaluated. Seventy-six percent of participants in the LSDS group achieved
habituation to their primary imaginal scene relative to 52% of HSDS participants. This disparity
approached statistical significance, χ2(1, 54) = 3.352, p = .067.
Sleep Medication
Sleep medication usage was examined to assess potential contributions to the findings.
Twenty LSDS (68.9%) and 17 HSDS (68%) participants reported using prescribed and/or over
the counter sleep medications. A chi-squared test indicated that there was not a different rate of
usage between groups, χ2(1, 54) = .006, p = .939. Additionally, after splitting the sample by sleep
medication use (use or no use), the means of the variables of interest did not appear to differ
significantly.
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CHAPTER 4: DISCUSSION
Growing empirical evidence supports the enhancing effects of sleep on extinction
learning. However, prior studies utilized conditioning and extinction learning paradigms and had
not examined this effect in (a) a clinical sample characterized by disturbed sleep or (b) in the
context of complex treatment provision (exposure therapy) rather than a basic learning paradigm.
In this investigation, indicators of extinction learning were examined in veterans with combatrelated PTSD who participated in an intensive, exposure-based treatment protocol and were
categorized into two groups by severity of sleep disturbances. Relative to participants with
HSDS, participants with LSDS exhibited greater extinction following VR-enhanced imaginal
exposure therapy. Specifically, veterans with LSDS habituated to the memories of their traumatic
event in fewer treatment sessions as indicated by significantly lower peak SUDS ratings during
latter exposure sessions. These findings are consistent with outcomes of individuals with spider
phobia who reported decreased subjective distress (Kleim et al., 2013) and decreased
sympathetic reactivity (Pace-Schott et al., 2012) to spider stimuli following a single session of
exposure therapy and a subsequent sleep period.
In addition to decreases in peak distress, baseline SUDS level decreased across imaginal
exposure sessions, a finding also reported for patients with flight phobia treated with VR
exposure therapy (Maltby, Kirsch, Mayers, & Allen, 2002). Baseline distress consists largely of
anticipatory anxiety, an anxious response to impending threatening or feared stimuli. Many of
the brain structures and regions implicated in processing present feared stimuli are also active
during anticipatory anxiety (Etkin & Wager, 2007). Therefore, reductions in baseline distress
would be expected to mirror those in peak distress level, as they did in this investigation.
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However, contrary to our hypothesis, LSDS participants did not report lower baseline distress
than HSDS participants. PTSD is differentiated from other anxious conditions in that the feared
stimuli are not environmentally based (and therefore capable of being avoided outside of
exposure therapy sessions). In PTSD, the “feared stimuli” are ever-present in the form of
traumatic memories. Thus, in this diagnostic group, baseline SUDS ratings may be more
representative of general arousal (or hyperarousal) levels, rather than anticipatory anxiety, and
may be less relevant as a metric of differential treatment outcome.
The LSDS and HSDS groups exhibited a similar pattern of decreasing self-reported
PTSD symptomatology from pretreatment through 1 week of treatment. After completing 2
weeks of treatment, the LSDS group reported significantly less symptom severity than the HSDS
group. This trend was magnified at posttreatment (conducted one week after the last treatment
session) when LSDS patients reported further decreases in self-reported PTSD symptomatology
while HSDS patients reported a significant increase in symptomatology. Newly-formed
memories, such as those formed by habituation and extinction learning, are strengthened over
time through sleep-driven consolidation and reconsolidation (Inda, Muravieva, & Alberini, 2011;
Pace-Schott, Germain, & Milad, 2015a; Stickgold & Walker, 2007). Thus, the inhibitory
associations formulated through exposure therapy appeared be strengthened by overall better
sleep quality in the LSDS group. However, the newly-formed inhibitory associations were less
robust in the HSDS group as measured by peak SUDS ratings and rate of habituation. In turn, the
fearful traumatic memories may have regained primacy, contributing to recovery of fear as
indicated by increased self-reported PTSD symptomatology and attenuated reductions in
clinician-rated symptomatology at posttreatment.
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Some researchers have expressed skepticism about the role of between-session
habituation in exposure therapy outcomes, highlighting to inconsistent findings linking betweensession habituation and outcome measures (Craske et al., 2008). However, a recent study found
that responder status and change in PTSD symptomatology were related to decreasing betweensession SUDS level (Sripada & Rauch, 2015). Similarly, our findings suggest that betweensession habituation is an important indicator of better exposure therapy outcome in combatrelated PTSD. The LSDS group achieved between-session habituation to their imaginal scene
sooner and more often, suggesting faster learning and/or faster memory consolidation. They also
reported less PTSD symptomatology at posttreatment than the HSDS group.
Although this investigation contributes unique data to the empirical literature, the
following limitations should be considered. The primary limitation was the reliance on a
retrospective self-report measure to assess quality of sleep. Participants completed the measure
during the posttreatment assessment and their assessment of sleep quality may have been
influenced by their response to treatment. However, perusal of the pretreatment PSQI-A
indicated that quality of sleep within in each group was similar in the month prior to initiating
TMT. Emerging empirical evidence suggests a reciprocal relationship between quality of sleep
and consolidation of extinction memory (Pace-Schott, Germain, & Milad, 2015b; Sturm, Czisch,
& Spoormaker, 2013). However, the interplay among quality of sleep, habituation, and
symptomatology throughout treatment could not be carefully examined with a measure of past
month sleep. Future research may further elucidate the role of sleep in exposure therapy for
PTSD by incorporating repeated polysomnography assessments throughout the course of
exposure. Specifically, future studies should aim to identify the dynamics of the sleep cycle as it
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relates to PTSD symptomatology during treatment. Additionally, PTSD symptomatology was
only assessed through 1 week posttreatment in this study. Longitudinal examinations are needed
to determine the duration or resilience of sleep-enhanced extinction learning from exposure
therapy for combat-related PTSD. Reducing the chronicity and relapse of PTSD in military
personnel would obviously increase long-term relief from this debilitating condition.
Identifying methods for improving sleep in PTSD samples appears to be imperative to
improving exposure therapy outcomes for this group. In this study, approximately 68% of
participants were prescribed sleep medications, yet most still met the PSQI-A cutoff for
significant PTSD-related sleep disturbances. An alternative (or adjunct) to medication may
include supplementing exposure-based interventions with behavioral strategies that target sleep
disruption. For instance, imagery rehearsal (IR) therapies and cognitive-behavioral therapy for
insomnia (CBT-I) have demonstrated some promise in improving posttraumatic sleep difficulties
(Nappi, Drummond, & Hall, 2012). At the core of the multiple iterations of IR therapy is sleep
education and creating a novel narrative of a nightmare (i.e., rescripting; Krakow & Zadra, 2006)
that is rehearsed daily. Some IR therapies also include elements of exposure (e.g., Exposure,
Relaxation, and Rescripting Therapy; Davis, 2009; Imagery Rehearsal and Exposure Therapy;
Long et al., 2011) and/or CBT-I (Ulmer, Edinger, & Calhoun, 2011). CBT-I consists of sleep
hygiene, stimulus control, and sleep restriction. Although there are preliminary data supporting
IR and CBT-I for PTSD-related sleep difficulties, few of these data are derived from randomized
controlled trials. Moreover, delivery of the interventions has not been standardized across studies
(Casement & Swanson, 2012; Nappi et al., 2012). The next step in identifying an efficacious and
efficient sleep supplement to exposure therapy for combat-related PTSD may be a randomized
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controlled trial comparing IR and CBT-I alone and exposure therapy supplemented by either
intervention. Researchers should also strive to identify whether particular sleep symptom profiles
in PTSD are more responsive to one sleep intervention than the other, given the considerable
variability in quality of sleep among veterans with the disorder (Straus, Drummond, Nappi,
Jenkins, & Norman, 2015).
To our knowledge, this is the first study to examine the impact of quality of sleep on
habituation/extinction learning during a multi-session, exposure-based intervention for combatrelated PTSD. Collectively, the results of this investigation begin to elucidate the role of sleep
during exposure-based interventions for PTSD. Specifically, we found that veterans with
combat-related PTSD reporting less disturbed sleep appear to experience greater extinction
learning and less symptomatology over the course of VR-enhanced imaginal exposure therapy.
Sleep may be an important target in future exposure-based interventions to maximize outcome.
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Table 1Sample Demographics and Characteristics
Low Sleep Disturbance
(N = 30)
Age M (SD)
36.63 (10.04)
Sex
Male
27
Female
3
Race
Caucasian
18
African American
6
Hispanic
5
Asian/Pacific Islander
0
Multiracial
1
Military Branch/Service
Army
23
Navy
1
Marine Corp
3
Air Force
3
Service Status
Active Duty
5
Discharged
25
SC Disability
19
TBI History
14

High Sleep Disturbance
(N = 25)
36.96 (8.57)
24
1
20
2
1
1
1
17
1
5
2
11
14
13
10

SC Disability: Service-connected disability through Veterans Administration; TBI: Traumatic
brain injury

Table 2 PSQI-A Descriptive Statistics
All
LSDS
N = 54
N = 30
Statistic
Mean
9.49
6.20
Standard dev.
4.55
2.92
Median
10.00
7.00

HSDS
N = 25
13.44
2.55
13.00

PSQI-A: Pittsburgh Sleep Quality Index – Addendum for PTSD
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Table 3 Means, Standard Deviations, and Between-group Comparisons of Symptomatology and
Habituation Measures
LSDS
HSDS
(N = 29)
(N = 25)
Variable
p
ηp2
d
PCL-M
Pre/Week 1
62.86 (9.86)
66.52 (8.66)
.157
.038
Week 2
49.76 (13.43)
55.76 (11.79)
.089
.054
Week 3
41.31 (13.04)
48.96 (12.74)
.034
.083
Post
35.45 (11.77)
53.08 (12.94)
<.001
.346
CAPS
Pre
93.81 (14.72)
99.00 (16.71)
.172
.037
Post
31.18 (16.71)
52.36 (23.83)
<.001
.218
Peak SUDS
Early
7.08 (0.81)
7.22 (0.56)
.446
.011
Mid
5.94 (1.21)
6.14 (1.07)
.528
.008
Late
3.90 (1.41)
4.85 (1.35)
.016
.107
Baseline SUDS*
Early
4.25 (1.51)
4.23 (1.64)
Mid
3.21 (1.42)
3.06 (1.38)
Late
2.14 (0.91)
2.51 (1.39)
Habituation Rate
8.65 (2.30)
10.36 (3.34)
.032
.596
*Post-hoc analyses were not performed for Baseline SUDS. PCL: PTSD Checklist – Military Version;
CAPS: Clinician-Administered PTSD Scale; SUDS: Subjective Units of Distress Scale.
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